Back to Search Start Over

Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.

Authors :
Rong, Zhe
Shen, Feifei
Wang, Ye
Sun, Li
Wu, Jing
Zhang, Hui
Yuan, Yongsheng
Jiang, Wenwen
Li, Xiao
Ji, Pan
Zhang, Kezhong
Source :
Neuroscience Letters. Jun2021, Vol. 756, pN.PAG-N.PAG. 1p.
Publication Year :
2021

Abstract

[Display omitted] • Peripheral sensory nerve was impaired in PD, MSA and PSP. • p-α-syn and p-tau in sural nerve may serve as novel biomarkers for differential diagnosis of PD, MSA and PSP. • Schwann cells might perform an important role in peripheral pathophysiological processes of PD, MSA and PSP. Differential diagnosis of Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear paralysis (PSP) is challenging. This study aimed to investigate the expression of phosphorylated α-synuclein (p-α-syn) and phosphorylated tau-protein (p-tau) in sural nerves from patients with PD, MSA and PSP to find biomarkers for differential diagnosis. Clinical evaluations and sural nerve biopsies were performed on 8 PD patients, 8 MSA patients, 6 PSP patients and 8 controls (CTRs). Toluidine blue staining was used to observe morphological changes in sural nerves. The deposition of p-α-syn and p-tau was detected by immunohistochemistry with semiquantitative evaluation. Locations of p-α-syn and p-tau were identified by double immunofluorescent staining. In case groups, the density of nerve fibres decreased with swollen or fragmented Schwann cells (SCs). All cases (22/22) but no CTRs (0/8) presented p-α-syn immunoreactivity with gradually decreasing semiquantitative levels among the PD (6.00 ± 2.07), MSA (5.00 ± 2.33) and PSP (3.50 ± 1.52) groups. p-tau aggregates were found in 7/8 MSA (1.88 ± 1.46) and 6/6 PSP (1.67 ± 0.52) patients but not in PD patients or CTRs. There were different expression patterns of p-α-syn and p-tau in PD, MSA and PSP patients. These findings suggest that peripheral sensory nerve injury exists in PD, MSA and PSP patients. With a different expression pattern and level, p-α-syn and p-tau in sural nerves may serve as novel biomarkers for differential diagnosis of PD, MSA and PSP. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03043940
Volume :
756
Database :
Academic Search Index
Journal :
Neuroscience Letters
Publication Type :
Academic Journal
Accession number :
150875325
Full Text :
https://doi.org/10.1016/j.neulet.2021.135964